0000899243-22-009760.txt : 20220307 0000899243-22-009760.hdr.sgml : 20220307 20220307191133 ACCESSION NUMBER: 0000899243-22-009760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220307 DATE AS OF CHANGE: 20220307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jamali Vafa CENTRAL INDEX KEY: 0001908985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41242 FILM NUMBER: 22719858 MAIL ADDRESS: STREET 1: C/O ZIMVIE INC. STREET 2: 10225 WESTMOOR DRIVE CITY: WESTMINSTER STATE: CO ZIP: 80021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZimVie Inc. CENTRAL INDEX KEY: 0001876588 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10225 WESTMOOR DRIVE CITY: WESTMINSTER STATE: CO ZIP: 80021 BUSINESS PHONE: 303-443-7500 MAIL ADDRESS: STREET 1: 10225 WESTMOOR DRIVE CITY: WESTMINSTER STATE: CO ZIP: 80021 FORMER COMPANY: FORMER CONFORMED NAME: ZB SpinCo Holdings, Inc. DATE OF NAME CHANGE: 20210803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-01 0 0001876588 ZimVie Inc. ZIMV 0001908985 Jamali Vafa 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 1 1 0 0 See Remarks Common Stock 2022-03-01 4 A 0 39186 A 39201 D Common Stock 2022-03-01 4 A 0 54789 A 93990 D Stock Option (right to buy) 32.26 2022-03-01 4 A 0 172206 A 2031-02-25 Common Stock 172206 172206 D Stock Option (right to buy) 32.42 2022-03-01 4 A 0 200276 A 2031-03-01 Common Stock 200276 200276 D On March 1, 2022, Zimmer Biomet Holdings, Inc. ("Zimmer Biomet") completed a pro rata spinoff distribution (the "Distribution") of shares of ZimVie Inc. ("ZimVie") common stock, par value $ 0.01 per share ("ZimVie Common Stock") to the holders of record of Zimmer Biomet common stock, par value $ 0.01 per share ("Zimmer Biomet Common Stock") on February 15, 2022. In connection with the Distribution, pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2022, between Zimmer Biomet and ZimVie (the "EMA"), all outstanding equity awards with respect to Zimmer Biomet Common Stock held by the Reporting Person were equitably adjusted and converted into equity awards with respect to ZimVie Common Stock, with such equitable adjustments determined based on (i) the volume weighted average trading price of Zimmer Biomet Common Stock on February 28, 2022 and (ii) the volume weighted average trading price of ZimVie common stock on March 1 through March 3, 2022. Represents the grant of restricted stock units with respect to ZimVie Common Stock ("ZimVie RSUs") upon the conversion of performance-based restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest on February 25, 2024. Reflects 15 shares of ZimVie Common Stock received in the Distribution in respect of shares of Zimmer Biomet Common Stock held by the Reporting Person as of the record date for the Distribution. Represents the grant of ZimVie RSUs upon the conversion of restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest ratably in four annual installments on the first four anniversaries of the grant date, March 1, 2021. 13,700 shares of ZimVie Common Stock included in this award vested on March 1, 2022. Represents the grant of stock options to purchase ZimVie Common Stock upon the conversion of stock options to purchase Zimmer Biomet Common Stock in accordance with the terms of the EMA. This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 25, 2021. This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 1, 2021. President and Chief Executive Officer /s/ Heather Kidwell, Attorney-in-Fact for Vafa Jamali 2022-03-07